β-Secretases, alzheimers disease, and down syndrome

Current Gerontology and Geriatrics Research

Volumn 2012, Issue , 2012, Pages

  Webb, Robin L ^a   Murphy, M Paul ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84858216645     PISSN: 16877063     EISSN: 16877071     Source Type: Journal    
DOI: 10.1155/2012/362839     Document Type: Review

References (77)

1. Sherman S. L., Allen E. G., Bean L. H., Freeman S. B., Epidemiology of Down syndrome Mental Retardation and Developmental Disabilities Research Reviews 2007 13 3 221 227 (Pubitemid 47613276)
2. Gardiner K., Costa A. C. S., The proteins of human chromosome 21 American Journal of Medical Genetics, Part C 2006 142 3 196 205 (Pubitemid 44298202)
3. Allen E. G., Freeman S. B., Druschel C., Hobbs C. A., O'Leary L. A., Romitti P. A., Royle M. H., Torfs C. P., Sherman S. L., Maternal age and risk for trisomy 21 assessed by the origin of chromosome nondisjunction: a report from the Atlanta and National Down Syndrome Projects Human Genetics 2009 125 1 41 52
4. Mann D. M., Prasher V. P., Neuropathology of Alzheimer's disease in down syndrome Down Syndrome and Alzheimer's Disease 2006 London, UK Radcliffe-Oxford 15 36
5. Abbott A., Dementia: a problem for our age Nature 2011 475 supplement 7355 S2 S4
6. Lejeune J., Gautier M., Turpin R., tude des chromasomes somatiques de neuf enfants mongoliens Comptes rendus hebdomadaires des séances de l'Académie des sciences 1959 248 11 1721 1722
7. McKhann G., Drachman D., Folstein M., Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease Neurology 1984 34 7 939 944 (Pubitemid 14076461)
8. Van Duijn C. M., Hendriks L., Cruts M., Hardy J. A., Hofman A., Van Broeckhoven C., Amyloid precursor protein gene mutation in early-onset Alzheimer's disease The Lancet 1991 337 8747 978
9. Hardy J. A., Higgins G. A., Alzheimer's disease: the amyloid cascade hypothesis Science 1992 256 5054 184 185
10. Selkoe D. J., Alzheimer's disease: genes, proteins, and therapy Physiological Reviews 2001 81 2 741 766 (Pubitemid 32267077)
11. Haass C., Hung A. Y., Selkoe D. J., Teplow D. B., Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid -protein precursor Journal of Biological Chemistry 1994 269 26 17741 17748
12. Haass C., Lemere C. A., Capell A., Citron M., Seubert P., Schenk D., Lannfelt L., Selkoe D. J., The Swedish mutation causes early-onset Alzheimer's disease by -secretase cleavage within the secretory pathway Nature Medicine 1995 1 12 1291 1296
13. Braak H., Braak E., Neuropathological stageing of Alzheimer-related changes Acta Neuropathologica 1991 82 4 239 259
14. Lassmann H., Bancher C., Breitschopf H., Wegiel J., Bobinski M., Jellinger K., Wisniewski H. M., Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ Acta Neuropathologica 1995 89 1 35 41
15. Smale G., Nichols N. R., Brady D. R., Finch C. E., Horton W. E., Evidence for apoptotic cell death in Alzheimer's disease Experimental Neurology 1995 133 2 225 230
16. Velasco M. E., Smith M. A., Siedlak S. L., Nunomura A., Perry G., Striation is the characteristic neuritic abnormality in Alzheimer disease Brain Research 1998 813 2 329 333 (Pubitemid 29009649)
17. Scheff S. W., Price D. A., Schmitt F. A., Mufson E. J., Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment Neurobiology of Aging 2006 27 10 1372 1384 (Pubitemid 44279897)
18. Masliah E., Mallory M., Hansen L., DeTeresa R., Alford M., Terry R., Synaptic and neuritic alterations during the progression of Alzheimer's disease Neuroscience Letters 1994 174 1 67 72 (Pubitemid 24205235)
19. Hardy J., Selkoe D. J., The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 2002 297 5580 353 356 (Pubitemid 34790756)
20. Kang J., Lemaire H. G., Unterbeck A., The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor Nature 1987 325 6106 733 736 (Pubitemid 17054046)
21. Hussain I., Powell D., Howlett D. R., Tew D. G., Meek T. D., Chapman C., Gloger I. S., Murphy K. E., Southan C. D., Ryan D. M., Smith T. S., Simmons D. L., Walsh F. S., Dingwall C., Christie G., Identification of a novel aspartic protease (Asp 2) as -secretase Molecular and Cellular Neurosciences 1999 14 6 419 427 (Pubitemid 30026585)
22. Thinakaran G., Koo E. H., Amyloid precursor protein trafficking, processing, and function Journal of Biological Chemistry 2008 283 44 29615 29619
23. Huse J. T., Doms R. W., Closing in on the amyloid cascade: recent insights into the cell biology of Alzheimer's disease Molecular Neurobiology 2001 22 13 81 98 (Pubitemid 32545343)
24. Selkoe D. J., Yamazaki T., Citron M., Podlisny M. B., Koo E. H., Teplow D. B., Haass C., The role of APP processing and trafficking pathways in the formation of amyloid -protein Annals of the New York Academy of Sciences 1996 777 57 64 (Pubitemid 26149170)
25. Suzuki N., Cheung T. T., Cai X. D., Odaka A., Otvos L., Eckman C., Golde T. E., Younkin S. G., An increased percentage of long amyloid protein secreted by familial amyloid protein precursor ( APP 717) mutants Science 1994 264 5163 1336 1340
26. Maruyama K., Tomita T., Shinozaki K., Kume H., Asada H., Saido T. C., Ishiura S., Iwatsubo T., Obata K., Familiar Alzheimer's disease-linked mutations at Val 717 of amyloid precursor protein are specific for the increased secretion of A 42(43) Biochemical and Biophysical Research Communications 1996 227 3 730 735 (Pubitemid 26387796)
27. Glabe C. G., Structural classification of toxic amyloid oligomers Journal of Biological Chemistry 2008 283 44 29639 29643
28. Selkoe D. J., Normal and abnormal biology of the -amyloid precursor protein Annual Review of Neuroscience 1994 17 489 517 (Pubitemid 24117040)
29. Cummings B. J., Satou T., Head E., Milgram N. W., Cole G. M., Savage M. J., Podlisny M. B., Selkoe D. J., Siman R., Greenberg B. D., Cotman C. W., Diffuse plaques contain C-terminal A 42 and not A 40: evidence from cats and dogs Neurobiology of Aging 1996 17 4 653 659
30. Lemere C. A., Lopera F., Kosik K. S., Lendon C. L., Ossa J., Saido T. C., Yamaguchi H., Ruiz A., Martinez A., Madrigal L., Hincapie L., Arango J. C., Anthony D. C., Koo E. H., Goate A. M., Selkoe D. J., Arango J. C., The E280A presenilin 1 Alzheimer mutation produces increased A 42 deposition and severe cerebellar pathology Nature Medicine 1996 2 10 1146 1150 (Pubitemid 26338637)
31. Vassar R., Bennett B. D., Babu-Khan S., Kahn S., Mendiaz E. A., Denis P., Teplow D. B., Ross S., Amarante P., Loeloff R., Luo Y., Fisher S., Fuller J., Edenson S., Lile J., Jarosinski M. A., Biere A. L., Curran E., Burgess T., Louis J. C., Collins F., Treanor J., Rogers G., Citron M., -Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE Science 1999 286 5440 735 741
32. Sinha S., Anderson J. P., Barbour R., Basi G. S., Caccaveffo R., Davis D., Doan M., Dovey H. F., Frigon N., Hong J., Jacobson-Croak K., Jewett N., Keim P., Knops J., Lieberburg I., Power M., Tan H., Tatsuno G., Tung J., Schenk D., Seubert P., Suomensaari S. M., Wang S., Walker D., Zhao J., McConlogue L., John V., Purification and cloning of amyloid precursor protein -secretase from human brain Nature 1999 402 6761 537 540
33. Yan R., Blenkowski M. J., Shuck M. E., Miao H., Tory M. C., Pauley A. M., Brashler J. R., Stratman N. C., Mathews W. R., Buhl A. E., Carter D. B., Tomasselll A. G., Parodl L. A., Helnrikson R. L., Gurney M. E., Membrane-anchored aspartyl protease with Alzheimer's disease -secretase activity Nature 1999 402 6761 533 537
34. Lin X., Koelsch G., Wu S., Downs D., Dashti A., Tang J., Human aspartic protease memapsin 2 cleaves the -secretase site of -amyloid precursor protein Proceedings of the National Academy of Sciences of the United States of America 2000 97 4 1456 1460 (Pubitemid 30118462)
35. Solans A., Estivill X., De La Luna S., A new aspartyl protease on 21q22.3, BACE2, is highly similar to Alzheimer's amyloid precursor protein -secretase Cytogenetics and Cell Genetics 2000 89 3-4 177 184
36. Ishii K., Ii K., Hasegawa T., Shoji S., Doi A., Mori H., Increased A 42(43)-plaque deposition in early-onset familial Alzheimer's disease brains with the deletion of exon 9 and the missense point mutation (H163R) in the PS-1 gene Neuroscience Letters 1997 228 1 17 20 (Pubitemid 27288526)
37. Stockley J. H., O'Neill C., The proteins BACE1 and BACE2 and -secretase activity in normal and Alzheimer's disease brain Biochemical Society Transactions 2007 35 3 574 576 (Pubitemid 46975079)
38. Hussain I., Christie G., Schneider K., Moore S., Dingwall C., Prodomain processing of Asp1 (BACE2) is autocatalytic Journal of Biological Chemistry 2001 276 26 23322 23328
39. Chou K. C., Insights from modeling the tertiary structure of human BACE2 Journal of Proteome Research 2004 3 5 1069 1072
40. Fukumoto H., Rosene D. L., Moss M. B., Raju S., Hyman B. T., Irizarry M. C., -secretase activity increases with aging in human, monkey, and mouse brain American Journal of Pathology 2004 164 2 719 725 (Pubitemid 38364685)
41. Miners J. S., Van Helmond Z., Kehoe P. G., Love S., Changes with age in the activities of -secretase and the a -degrading enzymes neprilysin, insulin-degrading enzyme and angiotensin-converting enzyme Brain Pathology 2010 20 4 794 802
42. Ahmed R. R., Holler C. J., Webb R. L., Li F., Beckett T. L., Murphy M. P., BACE1 and BACE2 enzymatic activities in Alzheimer's disease Journal of Neurochemistry 2010 112 4 1045 1053
43. Fukumoto H., Cheung B. S., Hyman B. T., Irizarry M. C., -secretase protein and activity are increased in the neocortex in Alzheimer disease Archives of Neurology 2002 59 9 1381 1389 (Pubitemid 35014802)
44. Yang L. B., Lindholm K., Yan R., Citron M., Xia W., Yang X. L., Beach T., Sue L., Wong P., Price D., Li R., Shen Y., Elevated -secretase expression and enzymatic activity detected in sporadic Alzheimer disease Nature Medicine 2003 9 1 3 4 (Pubitemid 36098241)
45. Mullan M., Houlden H., Windelspecht M., Fidani L., Lombardi C., Diaz P., Rossor M., Crook R., Hardy J., Duff K., Crawford F., A locus for familial early-onset alzheimer's disease on the long arm of chromosome 14, proximal to the 1-antichymotrypsin gene Nature Genetics 1992 2 4 340 342
46. Roberds S. L., Anderson J., Basi G., Bienkowski M. J., Branstetter D. G., Chen K. S., Freedman S. B., Frigon N. L., Games D., Hu K., Johnson-Wood K., Kappenman K. E., Kawabe T. T., Kola I., Kuehn R., Lee M., Liu W., Motter R., Nichols N. F., Power M., Robertson D. W., Schenk D., Schoor M., Shopp G. M., Shuck M. E., Sinha S., Svensson K. A., Tatsuno G., Tintrup H., Wijsman J., Wright S., McConlogue L., BACE knockout mice are healthy despite lacking the primary -secretase activity in brain: implications for Alzheimer's disease therapeutics Human Molecular Genetics 2001 10 12 1317 1324 (Pubitemid 32600485)
47. Willem M., Garratt A. N., Novak B., Citron M., Kaufmann S., Rittger A., DeStrooper B., Saftig P., Birchmeier C., Haass C., Control of peripheral nerve myelination by the -secretase BACE1 Science 2006 314 5799 664 666 (Pubitemid 44646394)
48. Chen X. H., Siman R., Iwata A., Meaney D. F., Trojanowski J. Q., Smith D. H., Long-term accumulation of amyloid-, -secretase, presenilin-1, and caspase-3 in damaged axons following brain trauma American Journal of Pathology 2004 165 2 357 371 (Pubitemid 38971368)
49. Blasko I., Beer R., Bigl M., Apelt J., Franz G., Rudzki D., Ransmayr G., Kampfl A., Schliebs R., Experimental traumatic brain injury in rats stimulates the expression, production and activity of Alzheimer's disease -secretase (BACE-1) Journal of Neural Transmission 2004 111 4 523 536 (Pubitemid 38478920)
50. Holler C. J., Webb R. L., Laux A. L., Beckett T. L., Niedowicz D. M., Ahmed R. R., Liu Y., Simmons C. R., Dowling A. L.S., Spinelli A., Khurgel M., Estus S., Head E., Hersh L. B., Murphy M. P., BACE2 expression increases in human neurodegenerative disease American Journal of Pathology 2012 180 1 337 350
51. Cheon M. S., Dierssen M., Kim S. H., Lubec G., Protein expression of BACE1, BACE2 and APP in Down syndrome brains Amino Acids 2008 35 2 339 343
52. Miners J. S., Morris S., Love S., Kehoe P. G., Accumulation of insoluble amyloid- in Down's syndrome is associated with increased BACE-1 and neprilysin activities Journal of Alzheimer's Disease 2011 23 1 101 108
53. Hook V., Funkelstein L., Wegrzyn J., Bark S., Kindy M., Hook G., Cysteine Cathepsins in the secretory vesicle produce active peptides: cathepsin L generates peptide neurotransmitters and cathepsin B produces beta-amyloid of Alzheimer's disease Biochimica et Biophysica Acta 2012 1824 1 89 104
54. Farzan M., Schnitzler C. E., Vasilieva N., Leung D., Choe H., BACE2, a -secretase homolog, cleaves at the site and within the amyloid- region of the amyloid- precursor protein Proceedings of the National Academy of Sciences of the United States of America 2000 97 17 9712 9717 (Pubitemid 30650841)
55. Barbiero L., Benussi L., Ghidoni R., Alberici A., Russo C., Schettini G., Pagano S. F., Parati E. A., Mazzoli F., Nicosia F., Signorini S., Feudatari E., Binetti G., BACE-2 is overexpressed in Down's syndrome Experimental Neurology 2003 182 2 335 345 (Pubitemid 36937086)
56. Cheon M. S., Dierssen M., Kim S. H., Lubec G., Protein expression of BACE1, BACE2 and APP in Down syndrome brains Amino Acids 2008 35 2 339 343
57. Lockstone H. E., Harris L. W., Swatton J. E., Wayland M. T., Holland A. J., Bahn S., Gene expression profiling in the adult Down syndrome brain Genomics 2007 90 6 647 660 (Pubitemid 350166832)
58. Sun X., He G., Song W., BACE2, as a novel APP -secretase, is not responsible for the pathogenesis of Alzheimer's disease in Down syndrome FASEB Journal 2006 20 9 1369 1376 (Pubitemid 44943845)
59. Fluhrer R., Capell A., Westmeyer G., Willem M., Hartung B., Condron M. M., Teplow D. B., Haass C., Walter J., A non-amyloidogenic function of BACE-2 in the secretory pathway Journal of Neurochemistry 2002 81 5 1011 1020 (Pubitemid 34809283)
60. Azkona G., Amador-Arjona A., Obradors-Tarrag C., Varea E., Arqué G., Pinacho R., Fillat C., De La Luna S., Estivill X., Dierssen M., Characterization of a mouse model overexpressing beta-site APP-cleaving enzyme 2 reveals a new role for BACE2 Genes, Brain and Behavior 2010 9 2 160 172
61. Azkona G., Levannon D., Groner Y., Dierssen M., In vivo effects of APP are not exacerbated by BACE2 co-overexpression: behavioural characterization of a double transgenic mouse model Amino Acids 2010 39 5 1571 1580
62. Watson D., Castao E., Kokjohn T. A., Kuo Y. M., Lyubchenko Y., Pinsky D., Connolly E. S., Esh C., Luehrs D. C., Blaine Stine W., Rowse L. M., Emmerling M. R., Roher A. E., Physicochemical characteristics of soluble oligomeric A and their pathologic role in Alzheimer's disease Neurological Research 2005 27 8 869 881 (Pubitemid 41790274)
63. Mori C., Spooner E. T., Wisniewski K. E., Wisniewski T. M., Yamaguchi H., Saido T. C., Tolan D. R., Selkoe D. J., Lemere C. A., Intraneuronal A 42 accumulation in Down syndrome brain Amyloid 2002 9 2 88 102 (Pubitemid 34787802)
64. Lu J., Esposito G., Scuderi C., Steardo L., Delli-Bovi L. C., Hecht J. L., Dickinson B. C., Chang C. J., Mori T., Sheen V., S100B and APP promote a gliocentric shift and impaired neurogenesis in down syndrome neural progenitors PLoS One 2011 6 7
65. Han B. H., Zhou M. L., Abousaleh F., Brendza R. P., Dietrich H. H., Koenigsknecht-Talboo J., Cirrito J. R., Milner E., Holtzman D. M., Zipfel G. J., Cerebrovascular dysfunction in amyloid precursor protein transgenic mice: contribution of soluble and insoluble amyloid- peptide, partial restoration via -secretase inhibition Journal of Neuroscience 2008 28 50 13542 13550
66. Chou K. C., Howe W. J., Prediction of the tertiary structure of the -secretase zymogen Biochemical and Biophysical Research Communications 2002 292 3 702 708 (Pubitemid 34681116)
67. Vilardell M., Rasche A., Thormann A., Maschke-Dutz E., Pérez-Jurado L. A., Lehrach H., Herwig R., Meta-analysis of heterogeneous Down Syndrome data reveals consistent genome-wide dosage effects related to neurological processes BMC Genomics 2011 12, article 229
68. Korbel J. O., Tirosh-Wagner T., Urban A. E., Chen X. N., Kasowski M., Dai L., Grubert F., Erdman C., Gao M. C., Lange K., Sobel E. M., Barlow G. M., Aylsworth A. S., Carpenter N. J., Clark R. D., Cohen M. Y., Doran E., Falik-Zaccai T., Lewin S. O., Lott I. T., McGillivray B. C., Moeschler J. B., Pettenati M. J., Pueschel S. M., Rao K. W., Shaffer L. G., Shohat M., Van Riper A. J., Warburton D., Weissman S., Gerstein M. B., Snyder M., Korenberg J. R., The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomies Proceedings of the National Academy of Sciences of the United States of America 2009 106 29 12031 12036
69. Krinsky-McHale S. J., Devenny D. A., Gu H., Jenkins E. C., Kittler P., Murty V. V., Schupf N., Scotto L., Tycko B., Urv T. K., Ye L., Zigman W. B., Silverman W., Successful aging in a 70-year-old man with down syndrome: a case study Intellectual and Developmental Disabilities 2008 46 3 215 228
70. Nieuwenhuis-Mark R. E., Diagnosing Alzheimer's dementia in Down syndrome: problems and possible solutions Research in Developmental Disabilities 2009 30 5 827 838
71. Devenny D. A., Krinsky-McHale S. J., Sersen G., Silverman W. P., Sequence of cognitive decline in dementia in adults with Down's syndrome Journal of Intellectual Disability Research 2000 44 6 654 665
72. Haxby J. V., Schapiro M. B., Longitudinal study of neuropsychological function in older adults with Down syndrome Progress in Clinical and Biological Research 1992 379 35 50
73. Rasmussen S. A., Whitehead N., Collier S. A., Fras J. L., Setting a public health research agenda for Down syndrome: summary of a meeting sponsored by the centers for disease control and prevention and the national down syndrome society American Journal of Medical Genetics, Part A 2008 146 23 2998 3010 (Pubitemid 352774639)
74. Edgin J. O., Mason G. M., Allman M. J., Capone G. T., DeLeon I., Maslen C., Reeves R. H., Sherman S. L., Nadel L., Development and validation of the Arizona Cognitive Test Battery for Down syndrome Journal of Neurodevelopmental Disorders 2010 2 3 149 164
75. Salomone S., Caraci F., Leggio G. M., Fedotova J., Drago F., New pharmacological strategies for treatment of Alzheimer's disease: focus on disease-modifying drugs. British Journal of Clinical Pharmacology. In press
76. Price J. L., McKeel D. W., Buckles V. D., Roe C. M., Xiong C., Grundman M., Hansen L. A., Petersen R. C., Parisi J. E., Dickson D. W., Smith C. D., Davis D. G., Schmitt F. A., Markesbery W. R., Kaye J., Kurlan R., Hulette C., Kurland B. F., Higdon R., Kukull W., Morris J. C., Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease Neurobiology of Aging 2009 30 7 1026 1036
77. Oster-Granite M. L., Parisi M. A., Abbeduto L., Berlin D. S., Bodine C., Bynum D., Capone G., Collier E., Hall D., Kaeser L., Kaufmann P., Krischer J., Livingston M., McCabe L. L., Pace J., Pfenninger K., Rasmussen S. A., Reeves R. H., Rubinstein Y., Sherman S., Terry S. F., SieWhitten M., Williams S., McCabe E. R.B., Maddox Y. T., Down syndrome: national conference on patient registries, research databases, and biobanks Molecular Genetics and Metabolism 2011 104 1-2 13 22